TITLE

Controlled Drugs

PUB. DATE
January 2002
SOURCE
Royal Society of Medicine: Medicines;2002, p171
SOURCE TYPE
Book
DOC. TYPE
Reference Entry
ABSTRACT
This article presents information on controlled drugs (CD) which are those designated under the British Misuse of Drugs Act, 1971 and Regulations and are believed most likely to cause dependence and lead to misuse. Class B includes oral amphetamines, barbiturates, cannabis, codeine and pholcodine. The Misuse of Drugs Regulations also define who is authorized to possess and supply CD, which are also divided into schedules that specify details to do with manufacture, record keeping and prescription.
ACCESSION #
18958869

 

Related Articles

  • A New Food and Drugs Act. ANDERSON, FLOYD // America;1/27/1934, Vol. 50 Issue 17, p395 

    The article reports on the pending bill in the U.S. Congress in January 1934 that would amend the 1906 Food and Drugs Act. It explores the defects of the 1906 Act, the abuses of drug manufacturers and the changes that will be incorporated in the bill. The author presents information on the...

  • Another caution against drug reimportation. Rose, Joan R. // Medical Economics;2/4/2005, Vol. 82 Issue 3, p13 

    Reports that the U.S. federal government must address some very significant safety and economic issues before permitting prescription drugs to be imported. Cost of regulating personal importation; Development of programs to enable residents to buy drugs from Canada or Europe.

  • COMMENTS CONCERNING THE APPLICATION INTO JUDICIAL PRACTICE OF THE PROVISIONS OF ART. 4, FROM LAW NO. 143/2000 ON COUNTERING THE ILLICIT DRUG USE AND TRAFICKING. Dima, Traian; Al-Kawadri, Lamya-Diana // LESIJ - Lex ET Scientia International Journal;2010, Vol. 17 Issue 1, p9 

    By studying the legal practice in the field of criminal provisions application regarding the prevention of and fight against illegal trafficking and consumption of drugs, the authors observe that in art. 4 of Law 143/2000 regarding the illegal drug holding for personal use, the interpretation...

  • A Quagmire for Our Time: The War on Drugs. Schrag, Peter // Journal of Public Health Policy;2002, Vol. 23 Issue 3, p286 

    The article presents a discussion on the problem of drug abuse in the United States. At least since 1996, when voters in California and Arizona approved ballot initiatives legalizing the medical use of marijuana, Americans have been trying to send the same message to Washington, D.C.: the...

  • New medicines law signed by Kazakhstani president.  // PharmacoEconomics & Outcomes News;3/27/2004, Issue 449, p11 

    Reports on a new law on medicines signed by Kazakhstani President Narsultan Nazybayev in 2004. Responsibilities of regional authorities in each of the functions regulated by the state; Scope of the law.

  • The Good News--and the Bad.  // Saturday Evening Post;Nov1974, Vol. 246 Issue 8, p38 

    Reveals that considerable sentiment is reported to exist on the U.S. Senate Subcommittee for altering the use of medical drugs through the imposition of more bureaucratic regulation. Remarks from Dr. Jan Koch-Weser about the role of potent drugs in life-threatening diseases; Factor that makes...

  • Orphan Drug Act Turns 25.  // BioWorld Today;1/14/2008, Vol. 19 Issue 9, p6 

    The article announces the 25th anniversary of the Orphan Drug Act, a landmark law that led to an increase in the number of therapies for rare and frequently untreated diseases. In the 25 years since the act was passed into law, more than 1,100 treatments for rare diseases have entered the...

  • Drug reform tips toes in the right direction. Kluewer, Susan T. // Long Island Business News (7/1993 to 5/2009);12/24/2004, Vol. 51 Issue 60, p10A 

    This article reports on the drug law, initiated in 1973 by the then-Governor Nelson G. Rockefeller. Known as the "Rockefeller Drug Laws," they severely limit traditional judicial discretionary power to fix the sentences of those convicted of felony sale or felony possession of controlled...

  • CMS issues Medicare Rx final rule.  // Drug Topics;2/7/2005, Vol. 149 Issue 3, p8 

    The pharmacy access standard in the U.S. has been changed to apply on a state-by-state, rather than regionwide basis under a final rule issued by CMS for the Medicare Rx drug benefit. The final rule allows certain non-retail pharmacies to be in Rx plan networks and will follow...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics